Cosciens Biopharma Inc. logo

Cosciens Biopharma Inc. (CSCI)

Market Closed
16 Jun, 20:00
TSX TSX
CA$
3. 02
-0.13
-4.127%
CA$
16.92M Market Cap
- P/E Ratio
- Div Yield
1,293 Volume
0 Eps
CA$ 3.15
Previous Close
Add Transaction
Day Range
2.98 3.24
Year Range
1.1 6
Want to track CSCI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Cosciens Biopharma Inc. (CSCI) Statistics

Valuation metrics

Market Cap 16.92M
Enterprise value -24.11M
Trailing P/E (ttm) -2.8
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 1.45
Price/Book (mrq) 0.55
Enterprise Value/Revenue -5.36
Enterprise Value/EBITDA 1.34

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.57K
Average volume (90 days) 4.05K

Price summary

52-Week low 1.1
52-Week high 6
Beta -
50-Day moving average 2.65
200-Day moving average 2.6

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 59:2,500
Last split Date 7 Jun 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.79%
Operating margin -4%

Operational effectiveness

Return on assets -0.1%
Return on equity -0.13%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.73
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 7.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 8.01%
Book value per share (mrq) 3.75

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -